Small-Scale Bioreactors Market Report 2026

The small-scale bioreactors market size has grown rapidly in recent years. It will grow from $2.48 billion in 2025 to $2.85 billion in 2026 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to growth in biologics research, need for scalable lab systems, academic-industry collaborations, improved bioprocess technologies, rising r&d investments.

The small-scale bioreactors market size is expected to see rapid growth in the next few years. It will grow to $5.09 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to expansion of cell therapy pipelines, increased biomanufacturing startups, demand for cost-effective systems, automation adoption, growth in emerging biotech hubs. Major trends in the forecast period include increased adoption of single-use bioreactors, rising demand from research labs, integration of automation systems, growth in modular bioprocessing, expansion of academic research funding.

The surge in biopharmaceutical research and development (R&D) investments is expected to significantly drive the growth of the small-scale bioreactors market in the coming years. Small-scale bioreactors are critical tools for process development in biopharmaceutical manufacturing. Researchers use these reactors to study and optimize parameters in cell culture, fermentation, and downstream processing before scaling up to larger production volumes, ensuring efficient, cost-effective processes that meet quality standards. For example, in 2023, the Office for National Statistics, a UK-based government agency, reported that the UK government’s net spending on R&D increased to £17.4 billion ($22.1 billion) in 2023, up from £16.1 billion ($20.45 billion) in 2022, representing an 8.2% rise. Consequently, increased R&D investments by biopharmaceutical companies are propelling the small-scale bioreactors market.

Key companies in the small-scale bioreactor market are focusing on innovative solutions, such as fixed-bed bioreactors, to enhance efficiency in bioprocessing and improve scalability for microbial and cell culture applications. A fixed-bed bioreactor is a system in which microorganisms or enzymes are immobilized on a solid support within a stationary bed, enabling continuous or batch processing of substrates as they flow through the reactor. For instance, in October 2024, Univercells Technologies, a Belgium-based biotechnology company, launched the Scale-XTM Nexo bioreactor, a miniaturized system designed to advance cell culture process development. This innovative bioreactor streamlines and accelerates development timelines for researchers, ultimately reducing costs by up to 60% compared to traditional methods.

In June 2023, Culture Biosciences Inc., a US-based cell and microbial culture platform provider, partnered with Cytiva Bioscience Holding Ltd to drive innovation in upstream bioprocessing. The collaboration aims to advance the development and manufacturing of new therapies by combining Culture Biosciences’ automated bioreactor technology with Cytiva’s bioprocessing expertise, improving efficiency, scalability, and innovation in biopharmaceutical production. Cytiva is a US-based life sciences company providing technologies and services that support the development and manufacture of biotherapeutics.

Major companies operating in the small-scale bioreactors market are Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Solaris Biotechnology Srl, Infors AG, Getinge AB, 2mag AG, Adolf Kuhner AG, Biosan, Esco Micro Private Limited, Hanil Scientific Inc., HiTec Zang GmbH, H.E.L Group, Finesse Solutions Inc., Applikon Biotechnology BV, PBS Biotech Inc., Danaher Corporation, Eppendorf AG, General Electric Company, Sartorius Stedim Biotech, Cytiva, Kuhner Shaker.

North America was the largest region in the small-scale bioreactors market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small-scale bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the small-scale bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have raised costs in the small-scale bioreactors market by increasing prices for imported sensors, control systems, disposable bags, and stainless-steel vessel components. Pharmaceutical companies, CROs, and academic institutes in Asia-Pacific and Europe are most affected due to reliance on international bioprocessing equipment suppliers. These higher costs can delay bioprocess development and pilot-scale production. However, tariffs are encouraging localized production of bioreactor systems and consumables, supporting long-term growth in the small-scale bioreactors market.

The small-scale bioreactors market research report is one of a series of new reports that provides small-scale bioreactors market statistics, including small-scale bioreactors industry global market size, regional shares, competitors with a small-scale bioreactors market share, detailed small-scale bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the small-scale bioreactors industry. This small-scale bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Small-scale bioreactors, also called laboratory-scale or pilot-scale vessels, are used for process development and optimization in biological experiments. They facilitate the cultivation of microorganisms, cells, or tissues and allow the study of biological processes under controlled conditions. These bioreactors are designed to replicate the environment required for the growth and metabolism of biological cultures.

The main product types in small-scale bioreactors include reusable bioreactors and single-use bioreactors. Reusable bioreactors are bioprocessing systems that can be sterilized and used for multiple batches of cell culture or fermentation. They are available in capacities of 5 mL-100 mL, 100 mL-250 mL, 250 mL-500 mL, 500 mL-1 L, 1 L-3 L, and 3 L-5 L. These systems are used with molecules such as monoclonal antibodies, stem cells, recombinant proteins, vaccines, and gene therapy products, and serve various end-users including pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), and academic and research institutes.

The small-scale bioreactors market consists of the sales of shake flasks, microtiter plates, benchtop bioreactors, bioreactor vessels, gas supply systems, fixed bed bioreactors, fluidized bed bioreactors, photo-bioreactors, single-use bioreactors (SUBs), perfusion bioreactors, hollow fiber bioreactors, spinner flasks, rotary drum bioreactors, and plug-flow bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.